home > events calendar > more about event

14th World Advanced Therapies & Regenerative Medicine Congress 2018


16-18 May 2018
Business Design Centre, London, United Kingdom

In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.

The event will take place alongside the co-located World Precision Medicine Congress, hosting300+ speakers, 10 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.

For a 15% discount on your conference ticket, quote code ‘HMFQ’ at the online checkout

Confirmed speakers include:

                   Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation

                   Sven Kili, Vice President & Head, Gene Therapy Development, GSK

                   Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

                   Margo Roberts, CSO, Kite Pharma

                   Sue Hill, Chief Scientific Officer, NHS

                   Brad Perkins, Chief Medical Officer, Human Longevity

                   Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

                   Paul P. Tak, Academic Medical Centre, University of Amsterdam;  Senior Vice President of Research & Development Pipeline, Chief Immunology Officer, GSK

                   Elizabeth Shpall, Director, MD Anderson Cancer Center

                   Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University

                   Todd McAllister, Executive Director, Amnion Foundation

                   Colleen Delaney, Founder and Chief Medical Officer, Nohla Therapeutics

                   Ajan Reginald, Chief Executive Officer, Celixir

                   Alain Vertès, Managing Director, NxR Biotechnologies

                   André Choulika, Chairman & Chief Executive Officer, Cellectis

                   Benjamin Shepherd, Director, Therapeutics, Organovo

                   Eduardo Bravo, Managing Director and CEO, TiGenix

                   Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

                   James Miskin, Chief Technical Officer, Oxford BioMedica

                   Jane Lebkowski, ‎President of R&D, Asterias Biotherapeutics

                   Jeff Abbey, CEO, Argos Therapeutics

                   John Tchelingerian, CEO, Promethera, Biosciences

                   Katy Spink, Chief Operating Officer, Asterias Biotherapeutics

                   Kristin Comella, Chief Science Officer, US Stem Cell Inc

                   Michael Stein, Chairman & CEO, Oxstem

                   Michael West, CEO, BioTime; CEO , AgeX Therapeutics

                   Nick Crabb, Programme Director – Scientific Affairs, NICE

                   Todd McAllister, Executive Director, Amnion Foundation

                   Yen Choo, CEO, Progenitor Therapeutics

                   Zami Aberman, Chairman & CEO, Pluristem Therapeutics

Key topics include:

                   The next generation of ATMPs

                   Regulation, reimbursement & commercialisation for advanced therapies around the globe

                   CRISPR & gene editing

                   Stem cells as a tool for drug discovery

                   What’s next for cell and gene therapy, new era of regenerative medicine?

                   New paradigms in manufacture: gene therapy & viral vectors

                   Clinical development of immunotherapy & cell therapy

                   New frontiers in repair and replacement of diseased tissues & organs

                   Product, process & manufacturing development of ATMPS

For a 15% discount on your conference ticket, quote code ‘HMFQ’ at the online checkout

phone +44 (0)20 7092 1000
email Business Design Centre, London
Print this page
Send to a friend
Industry Events

10th Annual NGS & Clinical Diagnostics Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 10thAnnual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Nordics_Events_97 on Samedan

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement